Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

3518 ARTÍCULOS , VIENDO DEL 2491 AL 2505

Progress towards a consensus on biomarkers for Alzheimer's disease: a review of peripheral analytes

Rembach A, Ryan TM, Roberts BR, Doecke JD, Wilson WJ, Watt AD, Barnham KJ, Masters CL.

Biomark Med. 2013 Aug;7(4):641-62. doi: 10.2217/bmm.13.59.

Neuroinflammation in Alzheimer's disease: an understanding of physiology and pathology

Obulesu M, Jhansilakshmi M.

Int J Neurosci. 2014 Apr;124(4):227-35. doi: 10.3109/00207454.2013.831852. Epub 2013 Sep 12.

[Alzheimer's disease and genetics]

Rongve A, Årsland D, Graff C.

Tidsskr Nor Laegeforen. 2013 Aug 6;133(14):1449-52. doi: 10.4045/tidsskr.12.0873.

Clinical pharmacology of novel anti-Alzheimer disease modifying medications

Caraci F, Bosco P, Leggio GM, Malaguarnera M, Drago F, Bucolo C, Salomone S.

Curr Top Med Chem. 2013;13(15):1853-63. doi: 10.2174/15680266113139990141.

Inflammatory components in human Alzheimer's disease and after active amyloid-β42 immunization

Zotova E, Bharambe V, Cheaveau M, Morgan W, Holmes C, Harris S, Neal JW, Love S, Nicoll JA, Boche D.

Brain. 2013 Sep;136(Pt 9):2677-96. doi: 10.1093/brain/awt210. Epub 2013 Aug 13.

Clinical assessment of amyloid imaging in Alzheimer's disease: a systematic review of the literature

Wahlster P, Niederländer C, Kriza C, Schaller S, Kolominsky-Rabas PL.

Dement Geriatr Cogn Disord. 2013;36(5-6):263-78. doi: 10.1159/000351679. Epub 2013 Aug 16.

Simulating effects of biomarker enrichment on Alzheimer's disease prevention trials: conceptual framework and example

Leoutsakos JM, Bartlett AL, Forrester SN, Lyketsos CG.

Alzheimers Dement. 2014 Mar;10(2):152-61. doi: 10.1016/j.jalz.2013.05.1776. Epub 2013 Aug 15.

Amyloid imaging: the court of public opinion

Lerner AJ.

Neurology. 2013 Sep 24;81(13):1108-9. doi: 10.1212/WNL.0b013e3182a55fe3. Epub 2013 Aug 21.

A comparison of early diagnostic utility of Alzheimer disease biomarkers in brain magnetic resonance and cerebrospinal fluid

Monge Argilés JA, Blanco Cantó MA, Leiva Salinas C, Flors L, Muñoz Ruiz C, Sánchez Payá J, Gasparini Berenguer R, Leiva Santana C.

Neurologia. 2014 Sep;29(7):397-401. doi: 10.1016/j.nrl.2013.06.002. Epub 2013 Aug 20.

Comparing predictors of conversion to Alzheimer's disease using the disease state index

Muñoz-Ruiz MÁ, Hall A, Mattila J, Koikkalainen J, Herukka SK, Vanninen R, Liu Y, Lötjönen J, Soininen H; Alzheimer’s Disease Neuroimaging Initiative.

Neurodegener Dis. 2014;13(2-3):200-2. doi: 10.1159/000354074. Epub 2013 Aug 22.

CD33 in Alzheimer's disease

Jiang T, Yu JT, Hu N, Tan MS, Zhu XC, Tan L.

Mol Neurobiol. 2014 Feb;49(1):529-35. doi: 10.1007/s12035-013-8536-1. Epub 2013 Aug 28.

From biomarkers to cytokine-like hormones: uncovering new directives for cognitive loss and Alzheimer's disease

Maiese K.

Curr Neurovasc Res. 2013 Nov;10(4):275-7. doi: 10.2174/15672026113109990033.

Biomarkers in pharmacology and drug discovery

Anderson DC, Kodukula K.

Biochem Pharmacol. 2014 Jan 1;87(1):172-88. doi: 10.1016/j.bcp.2013.08.026. Epub 2013 Aug 31.

Progress update: fluid and imaging biomarkers in Alzheimer's disease

Sutphen CL, Fagan AM, Holtzman DM.

Biol Psychiatry. 2014 Apr 1;75(7):520-6. doi: 10.1016/j.biopsych.2013.07.031. Epub 2013 Sep 5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias